MRK

Merck & Co
D

MRK

89.230
USD
1.63
(1.86%)
Pre Open
Volume
6,752
EPS
9
Div Yield
3.54
P/E
13
Market Cap
225,398,213,695
Signals
sara abdelazim
sara abdelazim
1 year ago
sell
MRK
MRK@109.27
2023-08-25 10:16
MRK@109.27 Chart
Profit
16.50
sara abdelazim
sara abdelazim
1 year ago
buy
MRK
MRK@109.65
2023-08-22 09:43
MRK@109.65 Chart
Profit
50.50
More
Related Instruments
ABBV
ABBV
2.500
(1.23%)
205.150 USD
AZN
AZN
0.950
(1.30%)
73.800 USD
BMY
BMY
1.120
(1.90%)
60.010 USD
GSK
GSK
0.235
(0.61%)
38.750 USD
JNJ
JNJ
0.580
(0.36%)
163.690 USD
LLY
LLY
0.36
(0.04%)
821.56 USD
NVO
NVO
-0.890
(-1.27%)
69.280 USD
PFE
PFE
0.175
(0.70%)
25.190 USD
SNY
SNY
0.900
(1.64%)
55.820 USD
More
News

Title: Merck & Co

Sector: Healthcare
Industry: Drug Manufacturers - General
Merck & Co. Inc. is an integrated healthcare company specializing in healthcare solutions through prescription medication, vaccines, biologic therapies, animal health, and consumer- care products. The company headquarters are in Rahway, New Jersey. The origins of the company stretch as far back as 1668, when it was founded by the Merck family in Germany. The American subsidiary of the German founding firm was established in 1891. Merck & Co. Inc. frequently features in the top 100 of the Fortune 500 list of biggest American firms by revenue.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.